News
The scientist, Dr. Fiona Havers, told colleagues at the Centers for Disease Control and Prevention on Monday that she no ...
A CDC official who oversaw the agency’s Respiratory Virus Hospitalization Surveillance Network, known as RESP-NET, has resigned, citing concerns about how the data will be used to inform vaccine ...
Moderna's shares fell 2.3% on Friday on concerns about whether a new CDC advisory panel would back the use of the company's ...
Covid-19 and RSV head data scientist dramatically quits saying she doesn’t trust RFK Jr department to use it ‘objectively’ - ...
The advisers to the Centers for Disease Control and Prevention will meet on June 25 and 26 to vote on who should receive shots for respiratory syncytial virus and influenza, according to a draft ...
Dr. Fiona Havers, a U.S. government scientist overseeing COVID-19 and RSV data, resigned, citing concerns over misuse of data ...
The FDA expanded its approval of Moderna's RSV vaccine on Thursday to include adults under age 60 at increased risk of the ...
2d
Zacks Investment Research on MSNEMA Accepts GSK's Filing for Expanded Use of RSV Vaccine ArexvyGSK plc GSK announced that the European Medicines Agency (EMA) has accepted the regulatory application seeking approval to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results